Study to Evaluate the Safety and Efficacy of VIRAZOLE ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19
Condition: COVID19 Interventions: Drug: 50 mg/mL Virazole; Drug: 100 mg/mL Virazole Sponsor: Bausch Health Americas, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials